Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2026.154386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Man Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, 061000, China. Hauptthemen laut MEDLINE: MicroRNAs, PTEN Phosphohydrolase, Hypertension, Pregnancy-Induced, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Gestational hypertension (GH) remains a major cause of maternal and fetal morbidity. miR-498 has been implicated in vascular dysfunction, yet its role and mechanism in GH remain unclear. METHODS: Clinical serum samples from 106 GH patients and 82 healthy pregnant controls were collected to detect circulating miR-498 expression and analyze its correlation with clinical parameters. The dual-luciferase reporter assay was applied to confirm the direct binding between miR-498 and PTEN. All in vitro functional experiments, including CCK-8 proliferation assay, Transwell migration and invasion assays, were conducted exclusively in HUVECs. RESULTS: Hsa-miR-498-5p (miR-498) was significantly downregulated in serum of GH patients and presented favorable diagnostic performance. Circulating miR-498 levels were negatively correlated with systolic blood pressure and neonatal birth weight, while positively correlated with gestational age. Mechanistically, miR-498 directly targeted PTEN. miR-498 overexpression enhanced the proliferative, migratory and invasive capacities of HUVECs, and ectopic PTEN overexpression could reverse these cellular phenotypes. CONCLUSION: Downregulated miR-498 aggravates endothelial dysfunction and facilitates GH progression via inhibiting PTEN/AKT signaling. This study identifies circulating miR-498 as a promising non-invasive diagnostic biomarker and reveals a vascular-specific regulatory axis for GH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, 061000, China.
- Office of Scientific Research, Cangzhou Medical College, Cangzhou, 061000, China.
- Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, 061000, China. Electronic address: XinBahedr@163.com.
Zitieren
APA
Chen, M., Zong, F., Zhang, J., Wang, Y., & Xing, B. (2026). Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.154386
Vancouver
Chen M, Zong F, Zhang J, Wang Y, Xing B. Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2026.154386
BibTeX
@article{Chen2026,
author = {Chen, Man and Zong, Fang and Zhang, Jingjing and Wang, Yaxuan and Xing, Baoheng},
title = {Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2026.154386}
}
EUVIMED